Sanofi: Clinical Trials & Research Profile
Biopharma Industry (Paris, FR / Cambridge, MA) · Primary Focus: Infectious Disease and Vaccines
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Paris, FR / Cambridge, MA) |
| Primary Therapeutic Area | Infectious Disease and Vaccines |
| Active Phase II & III Studies | 103 active (48 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 328 (180 with California sites) |
| Completed vs Early-Stopped Studies | 152 completed / 73 stopped (22.3% stop rate) |
| Median Closed Enrollment | 223 participants |
| FDA Drugs@FDA Original Approvals | 132 all-time (11 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 27.3% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Sanofi across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk